Caleres Inc (CAL) Stock News

A securities class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly stated coverage would begin July 1, 2026, while concealing material adverse facts about the actual timeline, causing investors to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

A class action lawsuit has been filed against ARS Pharmaceuticals for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product (neffy) with CVS Caremark. The company reportedly expressed confidence that coverage would begin July 1, 2026, while failing to adequately disclose risks that the deadline might not be met, potentially impacting summer and back-to-school sales.

A securities class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (SPRY) for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly misled investors about expected July 1, 2026 coverage, causing shareholders to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

Rosen Law Firm announces class action securities lawsuits against ARS Pharmaceuticals (SPRY) and Datavault AI (DVLT), with October 5, 2026 deadline for investors to join. ARS Pharmaceuticals is accused of providing misleading statements regarding insurance coverage expansion timeline for its epinephrine spray product neffy through CVS Caremark, allegedly causing investors to purchase shares at artificially inflated prices.

A securities class action lawsuit has been filed against ARS Pharmaceuticals (SPRY) for allegedly providing false and misleading statements regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company allegedly misled investors about a July 1, 2026 coverage start date, causing shareholders to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

The Pacer US Small Cap Cash Cows ETF (CALF) is a passively managed fund with $3.75 billion in assets that provides exposure to small-cap value stocks. With a 0.59% expense ratio, it is relatively expensive compared to alternatives. The ETF has performed well with 25.24% gains year-to-date and 26.35% over the past year, earning a Zacks ETF Rank of 3 (Hold). Cheaper alternatives like Vanguard Morningstar Small-Cap Value ETF (0.05% expense ratio) and iShares Russell 2000 Value ETF (0.24% expense ratio) are available.

A securities class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (SPRY) for allegedly providing misleading statements to investors regarding the timeline for expanded insurance coverage of its epinephrine nasal spray product 'neffy' through CVS Caremark. The company reportedly made confident statements about July 1, 2026 coverage while concealing material adverse facts, causing investors to purchase securities at artificially inflated prices. The lead plaintiff deadline is October 5, 2026.

UMH Properties, Inc., a REIT specializing in manufactured home communities, announced it will host its Third Quarter 2026 Financial Results Webcast and Conference Call on November 3, 2026. The company will release Q3 2026 results on November 2, 2026, and discuss market conditions and future outlook with senior management.

A class action lawsuit has been filed against ARS Pharmaceuticals (NYSE:SPRY) for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product 'neffy' with CVS Caremark. The company reportedly expressed confidence that coverage would begin July 1, 2026, while failing to disclose risks of delays that would impact summer and back-to-school seasons. Investors who purchased ARS securities between March 9 and June 24, 2026 can apply to be lead plaintiff by October 5, 2026.

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by directors and officers of Calix, Inc. The law firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. The investigation focuses on shareholders who purchased shares before January 28, 2026.

Law firm Kirby McInerney LLP is investigating potential securities fraud claims against Alnylam Pharmaceuticals following the company's announcement on July 30, 2026, that it lowered TTR product sales guidance by approximately $200 million due to normalization of growth in the ATTR-CM market after satisfying pent-up demand. The stock fell 28% ($81.14 per share) to $205.48 on the news.

Value Line, Inc. reported fiscal year 2026 net income of $21.63 million ($2.30 per share), up 4.6% from the prior year. The company declared a quarterly dividend of $0.35 per share, marking the 12th consecutive year of increases, with an annualized rate of $1.40 per share. Investment gains nearly doubled to $6.43 million, while liquid assets increased 11.7% to $86.47 million and shareholders' equity grew 8.2% to $107.89 million.

Class action lawsuits have been filed against AeroVironment, Calix, Zoetis, and Lucid Group, alleging that company executives made materially false statements and failed to disclose material adverse facts about their businesses. The lawsuits cover various issues including understated competition, supply chain problems, declining product adoption, and manufacturing disruptions. Lead plaintiff deadlines range from July 27-28, 2026.

A class action lawsuit has been filed against Calix, Inc. for allegedly making materially false statements about gross margins during Q1 2026. The company failed to disclose that its margins benefited from advanced memory component purchasing and that it faced significant margin pressure as this supply dwindled. The stock fell 13.98% on April 22, 2026 following the earnings announcement. The deadline to file a lead plaintiff motion is July 27, 2026.

J & J Snack Foods Corp. (JJSF) announced it will release financial results for fiscal Q3 ended June 27, 2026, on August 5, 2026, before market open. The company will host a conference call and webcast at 10:00 a.m. ET to discuss results. Investors can pre-register for the call via the company's investor relations website.

Rosen Law Firm is notifying investors in Calix, Inc., Embecta Corp., and Lucid Group, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding financial performance and business operations during specified class periods.

Rosen Law Firm is encouraging investors who suffered losses in Calix, Inc., Microsoft Corporation, and Alarum Technologies Ltd. to join securities class action lawsuits. The Calix lawsuit alleges the company made false statements about margins by failing to disclose that advanced memory component purchases were dwindling and that the company faced negative margin pressure. A July 27, 2026 deadline applies for lead plaintiff claims in the Calix case.

Law firm Bragar Eagel & Squire is investigating Zscaler for potential securities law violations following the company's May 27, 2026 announcement of weaker-than-expected guidance and sales leadership disruptions. Despite beating quarterly expectations, the guidance miss and execution concerns triggered a 31.52% single-day stock decline, marking the steepest drop since the company's IPO.

A securities fraud class action has been filed against Calix, Inc. for allegedly making materially false statements about gross margins during Q1 2026. The company failed to disclose that margin benefits came from advanced purchasing of memory components that had run out, leading to negative margin pressure. Calix stock fell 13.98% on April 22, 2026 following the earnings announcement. Investors have until July 27, 2026 to file a lead plaintiff motion.

Calix, Inc. (CALX) faces a securities class action lawsuit alleging management concealed that record gross margins were artificially sustained by pre-purchased low-cost memory inventory nearing exhaustion. Shares fell 13.98% ($6.93) from a peak of $55.61 on February 20, 2026 to $42.65 on April 22, 2026 following corrective disclosures. Institutional investors who purchased during the January 28 - April 21, 2026 class period may seek lead plaintiff status.

Brancous LP1, a shareholder of Braemar Hotels & Resorts, criticizes the Board for wasting company resources attacking shareholders instead of negotiating a lower Ashford termination payment. The shareholder claims the Board is pursuing a 'stealth liquidation' through asset sales to trigger a $480 million Change of Control payment to Ashford, which Brancous estimates at $7.00 per share. Brancous demands the Board declare a special dividend of at least $1.00 per share, renegotiate the Ashford payment, and allow shareholders to elect an independent Board.

A class action lawsuit has been filed against Calix, Inc. (NYSE: CALX) alleging the company misled investors about its business prospects during Q1 2026. Shareholders claim Calix failed to disclose that its margin benefits came from advanced memory component purchases, that supplies were dwindling, and that the company faced negative margin pressure. The stock fell 13.98% on April 22, 2026 when the truth was revealed. The lead plaintiff deadline is July 27, 2026.

Gray Media, Inc. announced it will release its Q2 2026 earnings results on August 7, 2026, followed by a conference call at 11:00 a.m. ET. The company is the nation's largest owner of local television stations, serving 117 markets reaching approximately 37% of US television households.

Rosen Law Firm reminds investors of Calix, Inc. (NYSE: CALX) who purchased securities between January 28, 2026 and April 21, 2026 of the July 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Calix made false statements about margins by failing to disclose that advanced memory component purchases were dwindling and the company faced negative margin pressure from rising component costs.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Calix, Inc. (NYSE: CALX) for allegedly making false and misleading statements about Q1 2026 margins. The company concealed that strong margins were artificially inflated by advanced memory component purchasing and failed to disclose dwindling supplies and upcoming negative margin pressure. When the truth emerged on April 21, 2026, CALX stock fell 13.98%, causing investor losses. The deadline to seek lead plaintiff appointment is July 27, 2026.

A securities class action lawsuit has been filed against Calix, Inc. alleging that the company made false and misleading statements regarding its margins. The lawsuit claims Calix benefited from advanced purchasing of memory components in Q1, but failed to disclose that its supply was dwindling and it faced negative margin pressure from rising component costs. The lead plaintiff deadline is July 27, 2026.

Rosen Law Firm announces securities class action lawsuits against Calix, Inc., Commvault Systems, Inc., and The Ensign Group, Inc. The Calix lawsuit alleges the company made false statements about margins by failing to disclose that advanced memory component purchases were dwindling and that the company faced negative margin pressure. Investors with losses exceeding $100,000 are encouraged to join the class action before the July 27, 2026 deadline.

A class action lawsuit has been filed against Calix, Inc. (NYSE:CALX) for allegedly making materially false and misleading statements about the company's margins and business prospects during the period of January 28, 2026 to April 21, 2026. The complaint alleges that Calix failed to disclose that first quarter margin benefits came from advanced memory component purchasing, that supplies were dwindling, and that the company faced negative margin pressure from rising component costs.

Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits against Calix, Inc., AeroVironment, Inc., and Lucid Group, Inc., alleging materially false statements and non-disclosure of material facts. Investors who purchased shares during specified periods and suffered losses are encouraged to seek legal representation.

Rosen Law Firm announces securities class action lawsuits against Calix, Inc., Verra Mobility Corporation, and Commvault Systems, Inc. The firm is seeking lead plaintiffs and reminding investors of important filing deadlines. The lawsuits allege that defendants made false or misleading statements regarding financial performance and business operations.